Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment

Saved in:
Bibliographic Details
Published in:Leukemia research 2017-04, Vol.55, p.S54-S54
Main Authors: Sebert, M, Bally, C, Peterlin, P, Beyne-Rauzy, O, Legros, L, Gourin, M.P, Sanhes, L, Wattel, E, Gyan, E, Park, S, Stamatoullas, A, Laribi, K, Banos, A, Jueliger, S, Chevret, S, Ades, L, Fenaux, P
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0145-2126
DOI:10.1016/S0145-2126(17)30198-4